scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1041255433 |
P356 | DOI | 10.1038/208143A0 |
P698 | PubMed publication ID | 4956920 |
P2093 | author name string | Charache P | |
Beck EA | |||
Jackson DP | |||
P2860 | cites work | CHEMISTRY AND PHYSIOLOGY OF THE FIBRINOGEN-FIBRIN TRANSITION. | Q35442552 |
A New Quantitative Method for Antigen–Antibody Titrations in Gels | Q58934996 | ||
[Rapid physiological coagulation method in determination of fibrinogen] | Q74515389 | ||
P433 | issue | 5006 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | blood coagulation disease | Q890200 |
P304 | page(s) | 143-145 | |
P577 | publication date | 1965-10-01 | |
P1433 | published in | Nature | Q180445 |
P1476 | title | A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore'). | |
P478 | volume | 208 |
Q35146858 | A Multiplex Allele Specific Polymerase Chain Reaction (MAS-PCR) for the Detection of Factor V Leiden and Prothrombin G20210A. |
Q70448317 | A report of a case of congenital afibrinogenemia |
Q45855059 | A variant of factor 8 related antigen |
Q53743719 | A ‘New’ Congenital Haemorrhagic Condition due to the Presence of an Abnormal Factor X (Factor X Friuli): Study of a Large Kindred |
Q43644299 | Active and Inactive Factor VII in Dubin-Johnson Syndrome with Factor-VII Deficiency, Hereditary Factor-VII Deficiency and on Coumadin Administration |
Q45877431 | An immunological investigation of factor VIII associated antigen in combined factor V and factor VIII deficiency |
Q36017106 | Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost |
Q37710079 | Chromatographic, ultracentrifugal, and related studies of fibrinogen “Baltimore” |
Q39624434 | Coagulopathies |
Q67862241 | Congenital dysfibrinogenemias: molecular abnormalities of fibrinogen |
Q72173549 | Congenital fibrinogen deficiency |
Q40369776 | Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin |
Q24600822 | Deficiency of protein C in congenital thrombotic disease |
Q67595513 | Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl) |
Q45855080 | Factor VIII immunological assay. An evaluation of several methods using whole plasma |
Q36704975 | Familial venous thrombosis |
Q44165893 | Fibrinogen Amsterdam, another hereditary abnormality of fibrinogen |
Q37509831 | Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis |
Q34063620 | Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release |
Q55061969 | Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen? |
Q34462314 | Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism |
Q34063930 | Functional evaluation of an inherited abnormal fibrinogen: fibrinogen “Baltimore” |
Q36738544 | Hereditary disorders of blood coagulation due to defective and deficient synthesis of protein |
Q44048852 | Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage |
Q50712797 | Heritable alpha 2-macroglobulin deficiency in a patient with arterial thrombosis: alpha 2-macroglobulin deficiency Irvine. |
Q71050559 | Heterogeneity of human fibrinogen |
Q71326218 | Isolation and characterization of fetal fibrinogen |
Q47386202 | Kinetic Properties and Molecular Size of Thrombin-activated Factor V |
Q45856964 | Molecular deficiencies of human blood coagulation |
Q51804641 | Prevalence of prothrombin gene mutation (G-A 20210 A) in general population: a pilot study. |
Q39935581 | Structural Aspects of the Fibrinogen to Fibrin Conversion |
Q38160849 | The fibrinolytic system in man. |
Q35145555 | The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation |
Search more.